Document Detail


Hemoglobin-based Oxygen Carrier (HBOC-201) and Escalating Doses of Recombinant Factor VIIa (rFVIIa) as a Novel Pre-hospital Resuscitation Fluid in a Swine Model of Severe Uncontrolled Hemorrhage.
MedLine Citation:
PMID:  20645681     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Abstract Exsanguinating hemorrhage and unavailability of blood are major problems in pre-hospital trauma care. We investigated if combining rFVIIa with HBOC-201 reduces blood loss and improves physiologic parameters compared to HBOC alone. Swine underwent liver injury and were resuscitated with HBOC-201 alone or HBOC+90, 180 or 360 μg/kg rFVIIa before hospital arrival at 240 min; animals survived to 72 hours. Blood loss was reduced; MAP, CI, transcutaneous oxygen saturation, and 72-hour survival improved in the 90 and 180 μg/kg rFVIIa groups. Lactate was cleared faster in the HBOC+rFVIIa 90 μg/kg group. Verification in a large, well-powered study is indicated.
Authors:
Anke Scultetus; Francoise Arnaud; Lewis Kaplan; Aryeh Shander; Nora Philbin; Jennifer Rice; Richard McCarron; Daniel Freilich
Publication Detail:
Type:  Journal Article     Date:  2010-07-20
Journal Detail:
Title:  Artificial cells, blood substitutes, and immobilization biotechnology     Volume:  39     ISSN:  1532-4184     ISO Abbreviation:  Artif Cells Blood Substit Immobil Biotechnol     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-03-07     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9431307     Medline TA:  Artif Cells Blood Substit Immobil Biotechnol     Country:  England    
Other Details:
Languages:  eng     Pagination:  59-68     Citation Subset:  IM    
Affiliation:
Naval Medical Research Center, Operational and Undersea Medicine Directorate, NeuroTrauma Department, Silver Spring, MD, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Left ventricular hypertrophy detection and body mass index in essential hypertension.
Next Document:  Novel GABA(B) receptor positive modulators: a patent survey.